Literature DB >> 2136482

[Seroepidemiology of amebiasis in the northern region of the Republic of Mexico].

A Isibasi1, C González, V Ortíz, M Muy, J Paniagua, F Blanco, R Pelayo, V Magdaleno, A Ramírez, J Kumate.   

Abstract

The object of paper has been the study of amebic seroepidemiology in the northern region of Mexico, by means of an immunoenzymatic assay in solid phase (ELISA). The proteic antigen was obtained from axenic culture of E. histolytica's trophozoites of strain HM1:IMSS, by means of solubilization with phenoxy polyethoxyethanol (Triton X-100). Standardization of the method was obtained by analysis of 80 sera from patients with both a clinical and radiologic diagnosis of amebic hepatic abscess and 80 sera from healthy patients. The sensitivity reached 95% and the specificity was 90.7%. 15,457 sera from eight Mexican northern states were tested as part of the National Seroepidemiologic Survey. A semiautomatic BIOMEK 1,000 (Beckman Ins.) equipment was used. The positive ratio varied between 2.0% in Southern Baja California and 4.92% in Chihuahua, with an average ratio for the whole group of 3.34%. The first three places, in descending order, are Chihuahua (4.92%), Sinaloa (4.01%) and Northern Baja California (3.78%). The positive man: woman ratio was 0.87:1 and fluctuated between 0.38:1 in Coahuila and 1.76:1 in Nuevo Leon. In the whole sample the positive ratio of men was 3.00% and in women was 3.43%. The antibody profile related to age, is similar to diseases reported to be highly endemic; the percentage of positive sera rose progressively up to the age of 20 years (4.05%), at which a plateau occurred with a slight descending tendency up to 60 years of age (3.54%), after which a clear descent in the positive index is seen. No important variations were observed when comparing groups of ages and sexes. The antibody level seems to show an inverse relationship with the incidence rate of amebiasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136482

Source DB:  PubMed          Journal:  Arch Invest Med (Mex)        ISSN: 0066-6769


  4 in total

1.  Prevalence of antibodies against Entamoeba histolytica in Mexico measured by ELISA.

Authors:  C R González; A Isibasi; V Ortiz-Navarrete; J Paniagua; J A García; A Ramirez; B Salvatierra; R Tapia; J Sepúlveda; G Gutiérrez
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

2.  Serosurvey of Entamoeba Histolytica Exposure among Tepehuanos Population in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Agar Ramos-Nevárez; Sandra Margarita Cerrillo-Soto; Carlos Alberto Guido-Arreola
Journal:  Int J Biomed Sci       Date:  2015-06

3.  Seroepidemiology of Entamoeba histolytica Infection in General Population in Rural Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Jesus Hernandez-Tinoco; Luis Francisco Sanchez-Anguiano
Journal:  J Clin Med Res       Date:  2015-04-08

4.  Entamoeba histolytica Infection in Female Sex Workers: A Matched Case-Control Study in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco; Sergio Estrada-Martinez; Alma Rosa Perez-Alamos; Agar Ramos-Nevarez; Sandra Margarita Cerrillo-Soto; Carlos Alberto Guido-Arreola
Journal:  J Clin Med Res       Date:  2017-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.